Evidence map›Paper›PMID 30102706›Full record

ArticlePloS one2018

Variability of core microbiota in newly diagnosed treatment-naïve paediatric inflammatory bowel disease patients.

T G J de Meij, E F J de Groot, C F W Peeters, N K H de Boer, C M F Kneepkens, A Eck, M A Benninga, P H M Savelkoul, A A van Bodegraven, A E Budding

Abstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Saudi consensus guidance for the diagnosis and management of inflammatory bowel disease in children and adolescents.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association · 2025
    Guideline
  3. Article
  4. Article
  5. The role of theFrontiers in microbiology · 2026
    Review
  6. Article
  7. Alistipes putredinis CCUG 45780BMC microbiology · 2025
    Article
  8. Article
  9. Bacterial dysbiosis in newly diagnosed treatment naïve pediatric ulcerative colitis in Saudi Arabia.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association · 2025
    Article
  10. Article
  11. Article
  12. Evolution of a Pathogenic Microbiome.Journal of clinical medicine · 2023
    Review
  13. Article
  14. Article
  15. Article
  16. Biometabolites ofNutrients · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

T G J de MeijDepartment of Paediatric Gastroenterology, VU University Medical Centre, Amsterdam, The Netherlands.ORCID 0000-0002-9022-2779
E F J de GrootDepartment of Gastroenterology and Hepatology, VU University Medical Centre, Amsterdam, The Netherlands.
C F W PeetersDepartment of Epidemiology & Biostatistics, VU University Medical Centre, Amsterdam, The Netherlands.
N K H de BoerDepartment of Gastroenterology and Hepatology, VU University Medical Centre, Amsterdam, The Netherlands.
C M F KneepkensDepartment of Paediatric Gastroenterology, VU University Medical Centre, Amsterdam, The Netherlands.
A EckDepartment of Medical Microbiology and Infection Control, VU University Medical Centre, Amsterdam, The Netherlands.
M A BenningaDepartment of Paediatric Gastroenterology, Emma Children's Hospital, Academic Medical Centre, Amsterdam, The Netherlands.
P H M SavelkoulDepartment of Medical Microbiology and Infection Control, VU University Medical Centre, Amsterdam, The Netherlands.
A A van BodegravenDepartment of Gastroenterology, Geriatrics, Internal-and Intensive Care Medicine (Co-MIK), Zuyderland Medical Centre, Heerlen-Sittard-Geleen, The Netherlands.
A E BuddingDepartment of Medical Microbiology and Infection Control, VU University Medical Centre, Amsterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND &

aimsIntestinal microbiota is considered to play a crucial role in the aetiology of inflammatory bowel disease (IBD). We aimed to describe faecal microbiota composition and dynamics in a large cohort of children with de novo (naïve) IBD, in comparison to healthy paediatric controls (HC).

methodsIn this prospective study, performed at two tertiary centres, faecal samples from newly diagnosed, treatment-naïve paediatric IBD patients were collected prior to bowel cleansing for colonoscopy (t0) and 1, 3 and 6 weeks and 3 months after initiation of therapy. The microbial profiles of Crohn's disease (CD) and Ulcerative colitis (UC) patients were compared with HC and linked to therapeutic response. Microbiota composition was analysed by IS-pro technology.

resultsMicrobial profiles of 104 new IBD-patients (63 CD, 41 UC, median age 14.0 years) were compared to 61 HC (median 7.8 years). IBD was mainly characterised by decreased abundance of Alistipes finegoldii and Alistipes putredinis, which characterize a healthy state microbial core. The classifier including these core species as predictors achieved an AUC of the ROC curve of .87. Core bacteria tended to regain abundance during treatment, but did not reach healthy levels.

conclusionFaecal microbiota profiles of children with de novo CD and UC can be discriminated from HC with high accuracy, mainly driven by a decreased abundance of species shaping the microbial core in the healthy state. Paediatric IBD can therefore be characterized by decreased abundance of certain bacterial species reflecting the healthy state rather than by the introduction of pathogens.

Indexed as

AdolescentCase-Control StudiesChildChild, PreschoolFemaleGastrointestinal MicrobiomeHumansIndividualityInflammatory Bowel DiseasesMale

Identifiers

PMID30102706
PMCPMC6089417

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.